Invos
Device Cerebral/Somatic Oximetry
PDI 10884521211117
General payments
$520,652
Research payments
$3,792,342
Through program year 2025, $520,652 in general payments and $3,792,342 in research payments were reported against Invos (Cerebral/Somatic Oximetry).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $130,067 | 765 |
| 2025 | Research | $1,338,543 | 94 |
| 2024 | General | $131,814 | 1,186 |
| 2024 | Research | $1,531,995 | 127 |
| 2023 | General | $114,364 | 808 |
| 2023 | Research | $867,609 | 44 |
| 2022 | General | $112,730 | 711 |
| 2022 | Research | $31,065 | 2 |
| 2021 | General | $31,679 | 1,210 |
| 2021 | Research | $23,130 | 2 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 39 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 34 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
4,680 general · 269 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.